SHR-A2102
- Generic Name
- SHR-A2102
Guangshengtang's Innovative Hepatitis B Drug Included in Breakthrough Therapy List
Fujian Guangshengtang Pharmaceutical Co., Ltd. announced that its innovative hepatitis B treatment drug, Neracorvir, has been added to the Breakthrough Therapy List, potentially accelerating its development. This inclusion recognizes the drug's significant clinical advantages and novel antiviral mechanism, distinguishing it from existing treatments.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath